Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8935
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation ; volume:13 ; number:1 ; day:10 ; month:3 ; year:2020 ; pages:1-18 ; date:12.2020
Epigenetics & chromatin ; 13, Heft 1 (10.3.2020), 1-18, 12.2020
- Creator
-
Trivedi, Archit
Mehrotra, Aanchal
Baum, Caitlin E.
Lewis, Brandon
Basuroy, Tupa
Blomquist, Thomas
Trumbly, Robert
Filipp, Fabian V.
Setaluri, Vijayasaradhi
Serna, Ivana L. de la
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13072-020-00333-z
- URN
-
urn:nbn:de:101:1-2020052819113992781838
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Trivedi, Archit
- Mehrotra, Aanchal
- Baum, Caitlin E.
- Lewis, Brandon
- Basuroy, Tupa
- Blomquist, Thomas
- Trumbly, Robert
- Filipp, Fabian V.
- Setaluri, Vijayasaradhi
- Serna, Ivana L. de la
- SpringerLink (Online service)
Other Objects (12)
BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
Discovery of Benzo (d) imidazole‐6‐sulfonamides as Bromodomain and Extra‐Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain
Mechanisms of resistance to inhibitors of bromodomain and extra-terminal domain (BET) proteins in MYC-driven medulloblastoma
Muscle hypertrophy in hypoxia with inflammation is controlled by bromodomain and extra-terminal domain proteins
Bromodomain and extra-terminal (BET) proteins target Moloney murine leukemia virus integration to transcription start sites
Dietary compound resveratrol is a pan-BET bromodomain inhibitor
Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Selectively Binding a Bromodomain
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
Discovery of Benzo (d) imidazole‐6‐sulfonamides as Bromodomain and Extra‐Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain
Mechanisms of resistance to inhibitors of bromodomain and extra-terminal domain (BET) proteins in MYC-driven medulloblastoma
Muscle hypertrophy in hypoxia with inflammation is controlled by bromodomain and extra-terminal domain proteins
Bromodomain and extra-terminal (BET) proteins target Moloney murine leukemia virus integration to transcription start sites
Dietary compound resveratrol is a pan-BET bromodomain inhibitor
Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Selectively Binding a Bromodomain
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
Discovery of Benzo (d) imidazole‐6‐sulfonamides as Bromodomain and Extra‐Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain
Mechanisms of resistance to inhibitors of bromodomain and extra-terminal domain (BET) proteins in MYC-driven medulloblastoma
Muscle hypertrophy in hypoxia with inflammation is controlled by bromodomain and extra-terminal domain proteins
Bromodomain and extra-terminal (BET) proteins target Moloney murine leukemia virus integration to transcription start sites
Dietary compound resveratrol is a pan-BET bromodomain inhibitor
Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Selectively Binding a Bromodomain